Abstract
Already in the 19th century, it was accepted that tissues display clot-promoting activity. The awareness that a single protein was accountable for this pro-coagulant effect led to the detection of tissue factor (tissue factor), but for many years it was thought that tissue factor activity was restricted to the activation of an auxiliary pathway that had little biological significance. Today tissue factor is recognised to be the primary biological initiator of the coagulation cascade. In silico studies have highlighted the high degree of structural similarity of tissue factor with the super family of interferon receptors. The cytokine class II receptor family has probably evolved from an ancient gene coding for a pre-eukaryotic extracellular protein. Tissue factor evolved from this protein and matching sequences are found in invertebrates, especially insects. From tissue factor, the other receptors evolved. Strikingly, the common evolutionary origin of tissue factor and cytokine receptors is reflected in identical signalling. The evolutionary origin of tissue factor is the subject of the present review.
Keywords: Chordates, cytokines receptors, tissue factor, prokariotic secretion system 2
Current Genomics
Title: Functional Evolution of Tissue Factor, the Archetype of the Cytokine Receptor Family
Volume: 6 Issue: 6
Author(s): C. A. Spek, M. V. Zoelen, S. H. Diks and M. P. Peppelenbosch
Affiliation:
Keywords: Chordates, cytokines receptors, tissue factor, prokariotic secretion system 2
Abstract: Already in the 19th century, it was accepted that tissues display clot-promoting activity. The awareness that a single protein was accountable for this pro-coagulant effect led to the detection of tissue factor (tissue factor), but for many years it was thought that tissue factor activity was restricted to the activation of an auxiliary pathway that had little biological significance. Today tissue factor is recognised to be the primary biological initiator of the coagulation cascade. In silico studies have highlighted the high degree of structural similarity of tissue factor with the super family of interferon receptors. The cytokine class II receptor family has probably evolved from an ancient gene coding for a pre-eukaryotic extracellular protein. Tissue factor evolved from this protein and matching sequences are found in invertebrates, especially insects. From tissue factor, the other receptors evolved. Strikingly, the common evolutionary origin of tissue factor and cytokine receptors is reflected in identical signalling. The evolutionary origin of tissue factor is the subject of the present review.
Export Options
About this article
Cite this article as:
Spek A. C., Zoelen V. M., Diks H. S. and Peppelenbosch P. M., Functional Evolution of Tissue Factor, the Archetype of the Cytokine Receptor Family, Current Genomics 2005; 6 (6) . https://dx.doi.org/10.2174/138920205774483025
DOI https://dx.doi.org/10.2174/138920205774483025 |
Print ISSN 1389-2029 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5488 |
Call for Papers in Thematic Issues
Advanced Computational Algorithms and Artificial Intelligence in Clinical Pharmacogenomics
In the era of personalized medicine, understanding the relationship between genetics and drug response is crucial. This issue delves into innovative methodologies, leveraging deep computational analysis and artificial intelligence, to enhance the field of Clinical Pharmacogenomics. The interdisciplinary approach harnesses the power of advanced high-throughput genotyping technologies, sophisticated computational analysis, ...read more
Applications of Single-cell Sequencing Technology in Reproductive Medicine
Single cell sequencing (SCS) technology utilizes individual cells' genetic material to sequence their genome, transcriptome, and epigenetics at the molecular level. It offers insights into cell heterogeneity and enables the study of limited biological materials. Since its recognition as a valuable technique in 2011, single cell sequencing has yielded numerous ...read more
Big Data in Cancer Research
Cancer is a significant threat to human life and health, remaining a highly aggressive killer. It is a leading cause of death worldwide and represents a crucial medical issue for humanity. However, in the past decade, the effectiveness of new synthetic anticancer agents has not matched the current clinical speculation. ...read more
Current Genomics in Cardiovascular Research
Cardiovascular diseases are the main cause of death in the world, in recent years we have had important advances in the interaction between cardiovascular disease and genomics. In this Research Topic, we intend for researchers to present their results with a focus on basic, translational and clinical investigations associated with ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Synthetic Routes to Symmetric Bisbenzimidazoles: A Review
Mini-Reviews in Organic Chemistry Probiotics for the Prevention and Treatment of Allergies, with an Emphasis on Mode of Delivery and Mechanism of Action
Current Pharmaceutical Design Insight to Pharmacokinetics of TKIs: Optimizing Practical Guidelines for Individualized Therapy
Current Drug Metabolism A PHACES Syndrome Unmasked by Propranolol Interruption in a Tetralogy of Fallot Patient: Case Report and Extensive Review on New Indications of Beta Blockers
Current Medicinal Chemistry Mechanisms of Resistance to Photodynamic Therapy
Current Medicinal Chemistry Modulation of Cancer Metabolism by Phytochemicals - A Brief Overview
Anti-Cancer Agents in Medicinal Chemistry The Effect of Claudin-5 Overexpression on the Interactions of Claudin-1 and -2 and Barrier Function in Retinal Cells
Current Molecular Medicine Neurotoxins: Free Radical Mechanisms and Melatonin Protection
Current Neuropharmacology Peptide Nucleic Acids (PNA)-DNA Chimeras Targeting Transcription Factors as a Tool to Modify Gene Expression
Current Drug Targets Gene Therapy for Lysosomal Storage Diseases: Progress, Challenges and Future Prospects
Current Pharmaceutical Design Practical Aspects in the Use of Biomarkers for the Development of Cancer Vaccines
Current Cancer Therapy Reviews IAPs, their Antagonists and their Role in Neurological Disease and Cancer
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents (Neuro)Transmitter Systems in Circulating Immune Cells: A Target of Immunopharmacological Interventions?
Current Medicinal Chemistry Pathogenesis of Type 1 Diabetes: Regulation of Adhesion Molecules and Immune Cell Trafficking
Current Immunology Reviews (Discontinued) Matrix Metalloproteinase Inhibitors: New Challenges in the Era of Post Broad-Spectrum Inhibitors
Current Pharmaceutical Design MicroRNAs: Modulators of Tooth Development
MicroRNA Genetic Predisposition to Neonatal Tumors
Current Pediatric Reviews An Update on Peptide Drugs for Voltage-Gated Calcium Channels
Recent Patents on CNS Drug Discovery (Discontinued) Transforming Growth Factor-β Signaling in Motor Neuron Diseases
Current Molecular Medicine Primary and Secondary Hypertriglyceridaemia
Current Drug Targets